Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 January 2008, Vol. 111, No. 2, pp. 939-944.
Prepublished online as a Blood First Edition Paper on October 2, 2007; DOI 10.1182/blood-2007-07-099283.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Appendix
Right arrow All Versions of this Article:
blood-2007-07-099283v1
111/2/939    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, D. L.
Right arrow Articles by Socie, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, D. L.
Right arrow Articles by Socie, G.
Related Collections
Right arrow Transplantation
Right arrow Free Research Articles
Right arrow Clinical Trials and Observations
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

TRANSPLANTATION

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party

Debra L. Friedman1,2, Alicia Rovo3, Wendy Leisenring1,2, Anna Locasciulli4, Mary E. D. Flowers1,2, Andre Tichelli3, Jean E. Sanders1,2, H. Joachim Deeg1,2, and Gerard Socie5

1 Fred Hutchinson Cancer Research Center, Seattle, WA; 2 University of Washington, Seattle; 3 University Hospital, Basel, Switzerland; 4 Ospedale San Camillo Circonvallazione Gianicolense, Rome, Italy; and 5 Hospital St Louis, Paris, France

As risk for secondary breast cancer is elevated among cancer survivors treated with conventional therapy, we sought to determine the risk among 3337 female 5-year survivors who underwent an allogeneic hematopoietic cell transplantation (HCT) at the Fred Hutchinson Cancer Research Center or at one of 82 centers reporting to the European Bone Marrow Transplant Registry. Risk was calculated using standardized incidence ratios (SIRs), and risk factors were evaluated with a multivariable Cox proportional hazards model. Fifty-two survivors developed breast cancer at a median of 12.5 (range: 5.7-24.8) years following HCT (SIR = 2.2). Twenty-five–year cumulative incidence was 11.0%, higher among survivors who received total body irradiation (TBI) (17%) than those who did not receive TBI (3%). In multivariable analysis, increased risk was associated with longer time since transplantation (hazard ratio [HR] for 20+ years after transplantation = 10.8), use of TBI (HR = 4.0), and younger age at transplantation (HR = 9.5 for HCT < 18 years). Hazard for death associated with breast cancer was 2.5 (95% CI: 1.1-5.8). We conclude that female survivors of allogeneic HCT are at increased risk of breast cancer and should be educated about the need for regular screening.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
P. D. Inskip, L. L. Robison, M. Stovall, S. A. Smith, S. Hammond, A. C. Mertens, J. A. Whitton, L. Diller, L. Kenney, S. S. Donaldson, et al.
Radiation Dose and Breast Cancer Risk in the Childhood Cancer Survivor Study
J. Clin. Oncol., August 20, 2009; 27(24): 3901 - 3907.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Janin, H. Murata, C. Leboeuf, J.-M. Cayuela, E. Gluckman, L. Legres, A. Desveaux, M. Varna, P. Ratajczak, J. Soulier, et al.
Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation
Blood, February 19, 2009; 113(8): 1834 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. D. Rizzo, R. E. Curtis, G. Socie, K. A. Sobocinski, E. Gilbert, O. Landgren, L. B. Travis, W. D. Travis, M. E. D. Flowers, D. L. Friedman, et al.
Solid cancers after allogeneic hematopoietic cell transplantation
Blood, January 29, 2009; 113(5): 1175 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
N. S. Majhail
Old and New Cancers after Hematopoietic-Cell Transplantation
Hematology, January 1, 2008; 2008(1): 142 - 149.
[Abstract] [Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020